Preventing complications in heparin-induced thrombocytopenia
- 1 September 2002
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 112 (3) , 85-89
- https://doi.org/10.3810/pgm.2002.09.1307
Abstract
HIT is a common, potentially catastrophic syndrome. Awareness and early diagnosis allow effective therapeutic intervention. Ineffective strategies include stopping heparin only and starting warfarin early. Use of alternative anticoagulants is improving patient outcomes. Lepirudin, argatroban, and danaparoid each have advantages and disadvantages; treatment should be tailored to each patient.This publication has 7 references indexed in Scilit:
- Erratum for vol. 97, p. 2574Blood, 2001
- Argatroban Anticoagulant Therapy in Patients With Heparin-Induced ThrombocytopeniaCirculation, 2001
- A Comparison of Danaparoid and Lepirudin in Heparin-induced ThrombocytopeniaThrombosis and Haemostasis, 2001
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced ThrombocytopeniaAnnals of Internal Medicine, 1997
- A 14-year study of heparin-induced thrombocytopeniaThe American Journal of Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995